We are live on ! Find out more
CNSP icon

CNS Pharmaceuticals
CNSP

7 hedge funds and large institutions have $55.2K invested in CNS Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.11% more ownership

Funds ownership: 0.01% → 0.12% (+0.11%)

46% less funds holding

Funds holding: 13 → 7 (-6)

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

81% less capital invested

Capital invested by funds: $297K → $55.2K (-$242K)

Holders
7
Holders Change
-6
Holders Change %
-46.15%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$92.5K
2
GSC
Ground Swell Capital
South Carolina
+$46.2K
3
TRCT
Tower Research Capital (TRC)
New York
+$20.8K
4
BC
Barrett & Company
Rhode Island
+$391
5
SS
SBI Securities
Japan
+$49

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$50.5K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$46.6K
3
Citadel Advisors
Citadel Advisors
Florida
-$38.8K
4
XT
XTX Topco
Cayman Islands
-$35.5K
5
CCM
Connective Capital Management
California
-$33.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$32.6K +$92.5K +1,891 +1,767%
GSC
2
Ground Swell Capital
South Carolina
$15.4K +$46.2K +945 New
TRCT
3
Tower Research Capital (TRC)
New York
$6.95K +$20.8K +426 New
BC
4
Barrett & Company
Rhode Island
$136 +$391 +8 New
MCM
5
MAI Capital Management
Ohio
$55 – – –
SS
6
SBI Securities
Japan
$20 +$49 +1 New
Bank of America
7
Bank of America
North Carolina
$12 – – –
Jane Street
8
Jane Street
New York
– -$50.5K -700 Closed
Geode Capital Management
9
Geode Capital Management
Massachusetts
– -$46.6K -645 Closed
Citadel Advisors
10
Citadel Advisors
Florida
– -$38.8K -536 Closed
XT
11
XTX Topco
Cayman Islands
– -$35.5K -492 Closed
CCM
12
Connective Capital Management
California
– -$33.7K -467 Closed
IWC
13
Integrated Wealth Concepts
Massachusetts
– -$30.1K -417 Closed
VF
14
Virtu Financial
New York
– -$20K -271 Closed
HF
15
HRT Financial
New York
– -$18K -260 Closed
Two Sigma Investments
16
Two Sigma Investments
New York
– -$11.2K -155 Closed
Goldman Sachs
17
Goldman Sachs
New York
– -$4.86K -67 Closed
SIM
18
Synergy Investment Management
Florida
– -$1 – –

CNSP Hedge Fund Activity: Q1 2025 in Review

7 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in CNS Pharmaceuticals (CNSP) for Q1 2025, worth a combined $55.2K — down 81% from $297K a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of CNSP and 4 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $92.5K. The largest seller was Jane Street, exiting entirely with an estimated $50.5K sold.

  • 7 institutional investors held CNS Pharmaceuticals (CNSP) as of Q1 2025, down from 13 in Q4 2024.
  • Funds reported $55.2K of CNS Pharmaceuticals stock for Q1 2025, down 81% quarter-over-quarter.
  • 4 funds opened new CNS Pharmaceuticals positions in Q1 2025 and 10 closed out, a net change of -6 holders.
  • The largest CNS Pharmaceuticals buyer in Q1 2025 was UBS Group, an estimated $92.5K added.
  • The largest CNS Pharmaceuticals seller in Q1 2025 was Jane Street, an estimated $50.5K sold.

Based on aggregated 13F filings for Q1 2025.